Skip to main content
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 2018 Jan 31;63(4):541–542. doi: 10.1038/s10038-017-0395-6

Correction: Genetic and clinical characteristics in Japanese hereditary breast and ovarian cancer: first report after establishment of HBOC registration system in Japan

Masami Arai 1,, Shiro Yokoyama 2, Chie Watanabe 3, Reiko Yoshida 1, Mizuho Kita 1, Megumi Okawa 4, Akihiro Sakurai 5, Masayuki Sekine 6, Junko Yotsumoto 7, Hiroyuki Nomura 8, Yoshinori Akama 9, Mayuko Inuzuka 2, Tadashi Nomizu 10, Takayuki Enomoto 6, Seigo Nakamura 2
PMCID: PMC9119227  PMID: 29386572

Since the advance online publication of this article, the authors of the above paper have noticed the current Table 5 was not the original one.

Table 5.

Prevalence of deleterious mutations in BRCA1 and BRCA2 based on this study

Family history of breast cancer or ovarian cancer Among first- and second-degree relatives No family history of breast or ovarian cancer Family history in only third- degree relatives
Breast cancer < 50 y + +
Ovarian cancer (at any age) + +
Patient’s history
 Breast cancer ≥ 50 y 2/58 9/58 6/24 1/8 0/26 0/8
3.4% 15.5% 25.0% 12.5% 0% 0%
 Breast cancer < 50 y 21/125 45/139 27/61 17/27 16/164 1/17
16.8% 32.4% 44.3% 63.0% 9.8% 5.9%
 Ovarian cancer with no breast cancer at any age 0/2 1/1 1/2 1/5 0/1
0% 100% 50.0% 20.0% 0%
 Breast cancer and ovarian cancer at any age 1/1 1/2 4/4 1/6
100% 50% 100% 16.7%
 Male breast cancer at any age 0/1 0/1 0/1
0% 0% 0%
 No breast cancer or ovarian cancer at any age 0/16 2/27 3/20 0/7 1/4 0/1
0% 7.4% 15.0% 0% 25.0% 0%

Article with correct Table 5 now appears in this issue. The online html and pdf versions have also been rectified.

The authors apologize for any inconvenience caused.

Footnotes

The original article can be found online at 10.1038/s10038-017-0355-1.


Articles from Journal of Human Genetics are provided here courtesy of Nature Publishing Group

RESOURCES